Evaluation of the effectiveness of the calcaneal spurs radiotherapy

The radiotherapy results of 46 calcaneal spurs were analysed. Patients were irradiated using fraction dose of 1.0 Gy, 1.5 Gy or 2.0 Gy up to total dose of 2.0-22.5 Gy. All patients previously had chronic pain in the plantar region influencing possibility of walking and not reacting for conventional...

Full description

Saved in:
Bibliographic Details
Published inChirurgia narzadow ruchu i ortopedia polska Vol. 68; no. 3; p. 191
Main Authors Miszczyk, Leszek, Woźniak, Grzegorz, Jochymek, Bozena, Trela, Krystyna, Urban, Andrzej
Format Journal Article
LanguagePolish
Published Poland 2003
Subjects
Adult
Aged
Aged, 80 and over
Dose-Response Relationship, Radiation
Evaluation Studies as Topic
Female
Heel Spur - physiopathology
Heel Spur - radiotherapy
Humans
Male
Middle Aged
Pain - etiology
Pain - radiotherapy
Pain Measurement
Radiotherapy Dosage
Time Factors
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:The radiotherapy results of 46 calcaneal spurs were analysed. Patients were irradiated using fraction dose of 1.0 Gy, 1.5 Gy or 2.0 Gy up to total dose of 2.0-22.5 Gy. All patients previously had chronic pain in the plantar region influencing possibility of walking and not reacting for conventional treatment. Whole group was periodically controlled after the treatment completion. The mean follow-up period was 12.5 months. The complete pain relief was observed in 9% cases one month after treatment and in 52% during the last control. The lack of analgetic effect was noted only in 3% cases as well one month after the treatment as during the last examination. Performed statistical analysis showed only inverse significant correlation between degree of pain relief six months after the treatment and duration of symptoms. Obtained results allow to form conclusion that radiotherapy of calcaneal spurs is easy, effective and safe way of analgetic treatment giving good results after low fraction and total delivered doses and that its efficacy depends on symptoms duration what is correlated to disease stage.